Kate Steiner (Stevenage, United Kingdom) and Nicholas Inston (Birmingham, United Kingdom) members of the Vascular Access & Renal Interventions Executive Board highlight their key sessions coming in the CX Vascular Access Challenges update.
The CX Vascular Access & Renal Interventions Programme tackles critical challenges in vascular access, featuring multiple podium-first datasets that provide valuable insights and evidence to guide practice and the management of complex cases.
Highlights include:
- Podium first: ACCESS 2: A randomised controlled multinational AVF trial evaluating outcomes following intra-operative periadventitial delivery of Sirolimus
- Podium first: 12-month outcomes from the WAVE study
- Podium first: Optimal treatment of cephalic arch stenosis based on recent Level 1 DCB and covered stent trial results
- Deep dive: Infected access – challenges in diagnosis and treatment
- Great debate: DCBs should not be the standard of care for vascular access stenosis
Register today to secure your place using our Early Bird rates for a limited time only. Don’t miss out!
